Holen Sie sich die Stockscreener-App
6.83
3.48%
0.23
Handel nachbörslich:
6.73
-0.10
-1.46%
Schlusskurs vom Vortag:
$6.60
Offen:
$6.64
24-Stunden-Volumen:
189.12K
Relative Volume:
0.88
Marktkapitalisierung:
$244.37M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
136.60
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
+3.80%
1M Leistung:
+18.37%
6M Leistung:
+37.98%
1J Leistung:
+32.11%
1-Tages-Spanne:
$6.51
$6.95
1-Wochen-Bereich:
$6.20
$6.95
52-Wochen-Spanne:
$3.6793
$7.99
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Vergleichen Sie LFCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.83 | 244.37M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
165.02 | 73.07B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.14 | 47.43B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.12 | 45.72B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.49 | 17.75B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.75 | 14.03B | 612.78M | -86.37M | -62.91M | -0.87 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025 - TradingView
Lifecore Biomedical Earnings: Key Q3 Financial Results Coming April 3What to Watch - StockTitan
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation - Markets Insider
Head to Head Comparison: Lifecore Biomedical (NASDAQ:LFCR) & BetterLife Pharma (OTCMKTS:PVOTF) - Defense World
(LFCR) Long Term Investment Analysis - Stock Traders Daily
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - Markets Insider
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services for BIO 300 - Contract Pharma
Humanetics Selects Lifecore Biomedical To Deliver CDMO Services Supporting Development Of BIO 300 For The Prevention Of Acute Radiation Syndrome - Marketscreener.com
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome - The Manila Times
Humanetics Partners with Lifecore Biomedical for Development of BIO 300 Radioprotective Agent Funded by the Department of Defense - Nasdaq
Humanetics Selects Lifecore Biomedical to Deliver CDMO - GlobeNewswire
Lifecore Secures Major Defense Contract: Inside the $5.1M Radiation Protection Drug Program - StockTitan
Steward Partners Investment Advisory LLC Has $202,000 Stock Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Learn to Evaluate (LFCR) using the Charts - Stock Traders Daily
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - Markets Insider
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Bought by Rhumbline Advisers - Defense World
Is Lifecore Biomedical, Inc. (LFCR) the Best Micro Cap Stock to Buy Now? - Insider Monkey
Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR) - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out - Markets Insider
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - Markets Insider
Lifecore Biomedical: We Are Not Playing To Make 5% Or 10% Here - Seeking Alpha
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences - The Manila Times
How Lifecore Biomedical Plans to Engage Investors at 3 Key Healthcare Conferences Next Month - StockTitan
When the Price of (LFCR) Talks, People Listen - Stock Traders Daily
Lifecore Biomedical (NASDAQ:LFCR) Trading 3.8% HigherHere's What Happened - MarketBeat
NASDAQ: LFCR Lawsuit NOTICE: Investors Who Lost Money With Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) Should Contact the Shareholders Foundation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - Markets Insider
Lifecore Biomedical (NASDAQ:LFCR) Stock Price Up 3.8% – Should You Buy? - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
(LFCR) Technical Data - Stock Traders Daily
Sept. 27th Deadline Alert: Investors Who Lost More Than $100,000 With Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Should Contact the Shareholders Foundation - ACCESS Newswire
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - Markets Insider
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference - The Manila Times
Exclusive: Lifecore Biomedical Leadership Team Takes Center Stage at Major BIO Investor Summit - StockTitan
(LFCR) Investment Analysis - Stock Traders Daily
Lifecore Biomedical’s Earnings Call: Growth Amid Challenges - TipRanks
This Lifecore Biomedical Insider Increased Their Holding In The Last Year - Yahoo Finance
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.46%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):